The fixation implant intended for spinal fusion, consists of a ONE-STEP locking mechanism, articulating spikes and various sizes to accommodate variations in patient anatomy. Aurora Spine received clearance from the U.S. Food and Drug Administration for the system in November 2013.
“As a company traded on the TSX Venture Exchange, this is a significant milestone for Aurora Spine and its global growth. We are pleased to offer the ZIP MIS Interspinous Fusion System in Canada and introduce Aurora Spine’s advanced, innovative, minimally invasive spine surgery technologies which are designed to improve spine patient outcomes, drive continued surgeon interests and provide unique benefits that deliver value to hospitals and patients,” said Trent J. Northcutt, president and CEO of Aurora Spine.
More articles on devices:
6 points on FDA panel physicians …and their payments from device companies
What is Stryker responsible for in the OtisMed settlement? 5 things to know
What happens when data links device company payments with physician decisions?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
